|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 3 405-416, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
V De Corte, C De Potter, D Vandenberghe, N Van Laerebeke, M Azam, H Roels, M Mareel and J Vandekerckhove
Laboratory of Physiological Chemistry, University of Ghent, Belgium.
A factor present in conditioned medium of COLO-16 human cancer cells causes fast spreading, fast plasma membrane ruffling, cell shape change, net translocation, stimulation of chemotaxis and growth arrest in human SK-BR-3 mammary cancer cells. Based on the spreading effect, the factor was purified to homogeneity and migrated as a 50 kDa protein in SDS-polyacrylamide gel electrophoresis. Addition of the purified 50 kDa factor to the target cells in culture results in tyrosine phosphorylation of the p185erbB2 receptor concomitant with a fast redistribution and clustering of the receptor. The 50 kDa factor is also specifically retained by affinity chromatography on the immobilized extracellular domain of p185erbB2. Antibodies directed against this domain also inhibit the induction of motility. These data suggest that the 50 kDa factor is a putative ligand of p185erbB2 in SK-BR-3 cells. Biochemical and immunological evidence further indicate that this factor differs from p185erbB2 ligands described so far. Its activity could play a role in the pathogenesis of breast cancer.
This article has been cited by other articles:
![]() |
J. G. Christensen, R. E. Schreck, E. Chan, X. Wang, C. Yang, L. Liu, J. Cui, L. Sun, J. Wei, J. M. Cherrington, et al. High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo Clin. Cancer Res., December 1, 2001; 7(12): 4230 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. J. Schelfhout, E. D. Coene, B. Delaey, S. Thys, D. L. Page, and C. R. De Potter Pathogenesis of Paget's Disease: Epidermal Heregulin-{alpha}, Motility Factor, and the HER Receptor Family J Natl Cancer Inst, April 19, 2000; 92(8): 622 - 628. [Abstract] [Full Text] [PDF] |
||||